3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
18
Carcinoma, Non-Small-Cell Lung
15
Lung Neoplasms
7
Breast Neoplasms
7
Triple Negative Breast Neoplasms
6
Neoplasms
5
Neoplasm Metastasis
5
Colorectal Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Head and Neck Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Carcinoma
2
Vaccinia
1
Uterine Cervical Neoplasms
1
Squamous Non-small Cell Lung Cancer
1
Rectal Neoplasms
1
Pathologic Complete Response
1
Pancreatic Ductal Adenocarcinoma
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
Melanoma
1
Locally Advanced Pancreatic Cancer
1
Gastric Adenocarcinoma
1
Gallbladder Cancer Unresectable
1
Diabetes Mellitus, Insulin-Dependent, 12
1
Colonic Neoplasms
1
Carcinoma, Pancreatic Ductal
1
Brain Neoplasms
1
Anal Cancer Metastatic
1
Interventions
Magnetic Resonance Spectroscopy
28
enzalutamide
27
Specimen Handling
21
apalutamide
18
Androgen Antagonists
16
Prednisone
15
Abiraterone Acetate
15
Radiosurgery
13
abiraterone
11
Radiotherapy
10
Docetaxel
10
Biopsy
9
darolutamide
8
Pluvicto
8
Nivolumab
8
niraparib
6
cabazitaxel
6
Surveys and Questionnaires
6
Radiation
6
Lutetium-177
6
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
6
gallium 68 PSMA-11
5
bicalutamide
5
Radiotherapy, Intensity-Modulated
5
Lutetium
5
Gonadotropin-Releasing Hormone
5
radium Ra 223 dichloride
4
pembrolizumab
4
luprolide acetate gel depot
4
cabozantinib
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Prostatic Neoplasms
×
130-nm albumin-bound paclitaxel
×
30 days
×
Clear all
No trials found.